The typical buprenorphine dosage for opioid use disorder is 2 mg to 8 mg. Buprenorphine comes as a sublingual tablet and is usually taken once per day. It’s important to take the buprenorphine dosage ...

In a milestone moment for chronic pain management, Tonix Pharmaceuticals announced on August 15, 2025, that its novel ...

HAYWARD, Calif., Aug. 26, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative ...

REDWOOD CITY, Calif., April 11, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative ...

This review highlights relevant physicochemical drug properties and formulation design considerations critical to quality and performance of the sublingual tablets. The oral mucosal lining offers a ...

Please provide your email address to receive an email when new articles are posted on . Use of sufentanil sublingual in a multimodal analgesic regimen may lower opioid utilization, lead to more rapid ...

Treatment was well tolerated with minimal effects on weight or blood pressure and discontinuation rate of 19% vs. placebo of 20.8% Data support the potential of Tonmya as a well-tolerated, centrally ...

The Breakthrough Therapy designation stems from the provisions of 《Food and Drug Administration Safety and Innovation Act》. It is designed to expedite the development and regulatory review of drugs ...

Galena Biopharma GALE, a biopharmaceutical company commercializing and developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today ...